Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.95 USD | -1.75% | -4.64% | +7.65% |
Apr. 01 | Liquidia Says US FDA Cleared to Approve Yutrepia to Treat Hypertension | MT |
Apr. 01 | Liquidia's Yutrepia Cleared for Potential FDA Approval Following Court Ruling | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.65% | 985M | |
+27.92% | 672B | |
+26.89% | 570B | |
-4.59% | 360B | |
+16.38% | 321B | |
+9.39% | 300B | |
+7.38% | 217B | |
-9.28% | 204B | |
+5.84% | 199B | |
-8.58% | 149B |
- Stock Market
- Equities
- LQDA Stock
- News Liquidia Corporation
- Liquidia : Unveils $21.7 Million Private Placement